453 related articles for article (PubMed ID: 34168407)
21. Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?
Quero Guillén JC; Groeneweg M; Jiménez Sáenz M; Schalm SW; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2002 Sep; 94(9):544-57. PubMed ID: 12587235
[TBL] [Abstract][Full Text] [Related]
22. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
Mittal VV; Sharma BC; Sharma P; Sarin SK
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
[TBL] [Abstract][Full Text] [Related]
23. Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial.
Wang JY; Bajaj JS; Wang JB; Shang J; Zhou XM; Guo XL; Zhu X; Meng LN; Jiang HX; Mi YQ; Xu JM; Yang JH; Wang BS; Zhang NP
J Dig Dis; 2019 Oct; 20(10):547-556. PubMed ID: 31448533
[TBL] [Abstract][Full Text] [Related]
24. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
[TBL] [Abstract][Full Text] [Related]
25. Management of hepatic encephalopathy in Germany: a survey among physicians.
Labenz C; Adarkwah CC; Wörns MA; Miehlke S; Hofmann WP; Buggisch P; Galle PR; Frieling T; Labenz J
Z Gastroenterol; 2020 Jan; 58(1):49-56. PubMed ID: 31931540
[TBL] [Abstract][Full Text] [Related]
26. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
Sharma P; Sharma BC; Agrawal A; Sarin SK
J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
[TBL] [Abstract][Full Text] [Related]
27. Management options for minimal hepatic encephalopathy.
Bajaj JS
Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):785-90. PubMed ID: 19090738
[TBL] [Abstract][Full Text] [Related]
28. Management of overt hepatic encephalopathy.
Sharma P; Sharma BC
J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S82-7. PubMed ID: 26041964
[TBL] [Abstract][Full Text] [Related]
29. Disaccharides in the treatment of hepatic encephalopathy.
Sharma P; Sharma BC
Metab Brain Dis; 2013 Jun; 28(2):313-20. PubMed ID: 23456517
[TBL] [Abstract][Full Text] [Related]
30. Advances in the evaluation and management of minimal hepatic encephalopathy.
Montgomery JY; Bajaj JS
Curr Gastroenterol Rep; 2011 Feb; 13(1):26-33. PubMed ID: 20924726
[TBL] [Abstract][Full Text] [Related]
31. Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial.
Sharma K; Pant S; Misra S; Dwivedi M; Misra A; Narang S; Tewari R; Bhadoria AS
Saudi J Gastroenterol; 2014; 20(4):225-32. PubMed ID: 25038208
[TBL] [Abstract][Full Text] [Related]
32. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy
Luo M; Xin RJ; Hu FR; Yao L; Hu SJ; Bai FH
World J Gastroenterol; 2023 Jan; 29(1):144-156. PubMed ID: 36683714
[TBL] [Abstract][Full Text] [Related]
33. Clinical management of type C hepatic encephalopathy.
Ridola L; Riggio O; Gioia S; Faccioli J; Nardelli S
United European Gastroenterol J; 2020 Jun; 8(5):536-543. PubMed ID: 32213035
[TBL] [Abstract][Full Text] [Related]
34. Minimal hepatic encephalopathy matters in daily life.
Bajaj JS
World J Gastroenterol; 2008 Jun; 14(23):3609-15. PubMed ID: 18595126
[TBL] [Abstract][Full Text] [Related]
35. Chinese guidelines on management of hepatic encephalopathy in cirrhosis.
Xu XY; Ding HG; Li WG; Jia JD; Wei L; Duan ZP; Liu YL; Ling-Hu EQ; Zhuang H; Hepatology CSO; Association CM
World J Gastroenterol; 2019 Sep; 25(36):5403-5422. PubMed ID: 31576089
[TBL] [Abstract][Full Text] [Related]
36. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
[TBL] [Abstract][Full Text] [Related]
37. Minimal hepatic encephalopathy: A review.
Nardone R; Taylor AC; Höller Y; Brigo F; Lochner P; Trinka E
Neurosci Res; 2016 Oct; 111():1-12. PubMed ID: 27153746
[TBL] [Abstract][Full Text] [Related]
38. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.
Nardelli S; Lattanzi B; Merli M; Farcomeni A; Gioia S; Ridola L; Riggio O
Hepatology; 2019 Nov; 70(5):1704-1713. PubMed ID: 31038758
[TBL] [Abstract][Full Text] [Related]
39. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
[TBL] [Abstract][Full Text] [Related]
40. The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies.
Ridola L; Cardinale V; Riggio O
Ann Gastroenterol; 2018; 31(2):151-164. PubMed ID: 29507462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
